Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1997015313) THERAPEUTIC USE OF HEMOGLOBIN IN PROMOTING WOUND HEALING
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/015313 International Application No.: PCT/US1996/013510
Publication Date: 01.05.1997 International Filing Date: 20.08.1996
Chapter 2 Demand Filed: 18.04.1997
IPC:
A61K 38/42 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
41
Porphyrin- or corrin-ring-containing peptides
42
Haemoglobins; Myoglobins
Applicants:
BAXTER INTERNATIONAL INC. [US/US]; One Baxter Parkway Deerfield, IL 60015, US
Inventors:
BURHOP, Kenneth, E.; US
LEPPANIEMI, Ari, K.; US
MALCOLM, Diana, S.; US
SOLTERO, Raluan; US
Agent:
BARRETT, Joseph, B.; Route 120 & Wilson Road WG2-3S Round Lake, IL 60073, US
Priority Data:
08/548,66726.10.1995US
Title (EN) THERAPEUTIC USE OF HEMOGLOBIN IN PROMOTING WOUND HEALING
(FR) UTILISATION THERAPEUTIQUE DE L'HEMOGLOBINE POUR FAVORISER LA CICATRISATION
Abstract:
(EN) A method for enhancing wound repair comprises administration of a therapeutic dose of hemoglobin in an amount from about 50 to 2500 mg/kg of body weight. Such hemoglobin administration partially reverses the eschemia resulting from acute blood loss, and accelerates the healing process at remote times greater than one week post-trauma.
(FR) Pour favoriser la cicatrisation, on fait appel à une méthode comportant l'administration d'hémoglobine à une dose thérapeutique, comprise entre 50 et 2500 mg/kg de poids corporel environ. Cette administration d'hémoglobine annule en partie les effets de l'ischémie due à une perte aiguë de sang et accélère la cicatrisation plus d'une semaine après le traumatisme.
Designated States: AU, CA, JP, NO
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
NO19981866EP0862440JPH11513709 CA2235548AU1996067799